WA-PHYSIO-CONTROL
Lebanon’s Red Cross Emergency Services (LRC), which provides approximately 80% of emergency responses in the nation of Lebanon, will equip its emergency response fleets with defibrillators from Physio-Control . The Lebanese Red Cross is a humanitarian organization established as an independent nonprofit organization.
Funded almost entirely by donations from Red Cross Movement partners, the LRC has purchased 100 Physio-Control LIFEPAK 1000 automated external defibrillator (AED) devices, distributed and installed by BISCO , to supply every ambulance in its fleet. The procurement of standard emergency response AEDs fleet wide reflects the LRC’s objective of standardizing the quality of care each Ambulance crew provides.
“Equipping our response teams with automated external defibrillators will help us raise the standard of the patient care we can provide,” said Mr. Abdallah Zogheib, Director of Emergency Medical Services (EMS). Previously there were only 42 devices for the whole service, meaning that the quality of our patient care could be variable. This purchase helps eliminate that variability.”
The LRC has 2,700 trained volunteer EMTs on its rosters across 46 EMS stations throughout Lebanon to respond to calls arriving on the “140” national medical emergency telephone line. The LRC is a founding member of the Secretariat General of the Organization of the Arab Red Crescent and Red Cross Societies, is part of the International Red Cross and Red Crescent Movement and a member of the International Federation of the Red Cross and Red Crescent Societies.
LRC emergency services are run almost entirely by volunteers, so operational, training and ease of use are important considerations for all equipment procurements. The LIFEPAK 1000 is readily operated with proficiency due to an easy-to-use interface and clear prompts and display screen. It is also highly adaptable for professional responders, featuring advanced capabilities that can speed the transition of cardiac patients to the next critical level of care. The device is capable of maximum defibrillation energy up to 360 joules and has a long battery life and rugged construction that can stand up to severe environments.
“By supplying the LRC with LIFEPAK defibrillators, we hope to raise the standard of care the service can provide across the board,” said Martine Forissier, Physio-Control Business Director for Middle East and Africa. “Equipping their ambulance service with these defibrillators supports them in standardizing training, protocols and quality of care. It is an honor to assist the LRC in working to provide world-class emergency services.”
About the LIFEPAK ® 1000 Defibrillator
The LIFEPAK 1000 defibrillator is an easy-to-use automated external defibrillator (AED) designed for professional responders. A large, intuitive screen displays graphics and ECG readings that are clear and easy to read. The LIFEPAK 1000 also features cprMAX™ Technology which minimizes CPR interruptions by allowing compressions to continue during AED charging. Info: www.physio-control.com/lifepak1000
About Physio-Control
Physio-Control, Inc. is headquartered in Redmond, Washington. The company was founded in 1955, operates in over 100 countries and is the world’s leading provider of professional emergency medical response solutions that predict or intervene in life threatening emergencies. The company’s products include LIFEPAK® monitor/defibrillators and automated external defibrillators, the LIFENET® System, HealthEMS® electronic patient care reporting (ePCR) software, LUCAS® 2 Chest Compression System, TrueCPRTM coaching device and implementation for PulsePoint mobile bystander response applications. Learn more at www.physio-control.com , or connect via www.facebook.com/physiocontrolinc , https://www.linkedin.com/company/physio-control-inc- Twitter: @PhysioControl
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150331005060/en/
Contact:
Physio-Control (USA)
Matt Fikse, +1-425-867-4208
matt.fikse@physio-control.com
or
OTTO
PR
Shaun Wootton, (EU) +44 (0)7796 338360
shaun@ottopr.co.uk
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis2.6.2025 13:00:00 CEST | Press release
ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG. “This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achieve sustained remission with current approved treatment.” About Myasthenia Gravis
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”2.6.2025 13:00:00 CEST | Press release
Learners will have access to Lenovo’s globally recognized supply chain expertise through real-world case studies and subject matter experts. Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.” As a preferred higher education institution tapped to team up with Lenovo to offer supply chain short-term learning, Bellevue will leverage the breadth and depth of Lenovo’s supply chain expe
Lifezone Metals Files Initial Assessment for the Kabanga Nickel Project in Tanzania2.6.2025 12:30:00 CEST | Press release
Vertically Integrated Plan includes Hydrometallurgical Refinery at Kahama $2.37 Billion After-Tax NPV (8%) and 22.9% After-Tax IRR at $8.49 per Pound Nickel Price Initial Assessment Proposes a 22-Year Mine Plan at Average 2.39% Nickel Equivalent Grade Webcast with Technical Leadership Team at 10 AM ET on Tuesday, June 3, 2025 Lifezone Metals Limited’s (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a hydrometallurgical refinery at Kahama. The study covers the Main, MNB, Kima, North, and Tembo zones and is based on the December 2024 Mineral Resource Update (refer to Lifezone’s December 5, 2024 news
Corpay Cross-Border Named an Official Partner of Real Madrid C.F.2.6.2025 12:00:00 CEST | Press release
Providing access to currency risk management and cross-border payments solutions Corpay, Inc.*, (NYSE: CPAY) a global leader in corporate payments, is pleased to announce that Corpay’s Cross-Border business has entered into an agreement with Real Madrid C.F. to become an Official Partner. Through this partnership, Real Madrid will be able to gain access to and utilise Corpay Cross Border’s innovative solutions to help mitigate foreign exchange exposure from their day-to-day business needs. "The Corpay Cross-Border team is elated to be named an Official Partner of Real Madrid, one of the world’s most widely recognized and followed sports franchises," said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “With our strong focus on growing the Corpay brand, as well as our currency risk management business, we are excited to partner with one of the most successful football clubs in the world.” About Corpay Corpay, Inc. (NYSE: CPAY) is a global S&P500 corporate payments co
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 20252.6.2025 12:00:00 CEST | Press release
Preliminary results highlight anti-tumor activity and favorable safety profiles of both B7-H4-targeting ADC and CDK2 inhibitorData underscore strength of emerging breast cancer pipeline as part of BeOne’s global transformation with next wave of innovation BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Poster presentations feature preliminary results of the dose escalation studies of two investigational molecules: BG-C9074, a novel B7-H4-targeting antibody-drug conjugate (ADC) in patients with advanced solid tumors, including breast cancer, and BG-68501, a cyclin-dependent kinase-2 inhibitor (CDK2i), in HR+/HER2- breast cancer patients with prior CDK4/6i exposure. “Presenting the first clinical data for two novel breast cancer candidates at ASCO 2025 marks a pivotal moment for BeOne,” said Mark Lanas
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum